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ABSTRACT  
Background: Crohn's disease is a chronic and recurrent inflammatory bowel disease that progresses slowly. Also CD patients have a large 
number of extra-intestinal manifestations.  
Objective: we sought to define the possible associations between inflammatory pathology and localization and on the other hand, inflammatory 
pathologies and the disease behavior 
Methods: A retrospective analytical study was carried out at the level of gastric and general surgery services of Western Algerian University 
Hospital of Sidi Bel Abbes region, during the period 2007-2019.  
Results Our study was based on a total sample of 295 cases involving 114 females (38.6%) and 181 males (61.4%) with a sex ratio of (1 .58). 
The location of the disease at the time of diagnosis was dominated by the ileo-caecal location (55.3%), of which 64.4% were associated with 
inflammatory pathology (IP). The majority of patients diagnosed with Crohn's disease had an inflammatory behavior and this for all age groups. 
The appendix, the ulcer and inflammatory anemia are most associated with Crohn’s disease. For inflammatory extra-intestinal manifestations, 
only group of patients with arthralgia had significantly higher rates in the 20-60 age groups. The mainly noted risk factors were appendectomy 
with (17.3%), smoking (22.4%) with a highly significant association, and alcoholism (6.1%).  
Conclusion According to our results the association of inflammatory pathology and crohn disease is more frequent in male and dominated by 
arthralgia as extra-intestinal manifestations lesions.  
Keywords: Crohn disease; Inflammatory pathology; disease behavior; inflammatory extra-intestinal manifestation. 
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INTRODUCTION: 
Crohn's disease (CD) is a chronic and recurrent 
inflammatory bowel disease that progresses slowly and is 
characterized by an inflammatory exacerbation and 
regression 1,2. 
Patients may develop one or more phenotypes during the 
course of their disease, and often progress from 
inflammatory disease to severe complications. 
Unfortunately, there is no cure for CD and most patients 
need at least one surgical resection 3. 
In addition, patients suffering from other gastrointestinal 
diseases may also have a large number of extra-intestinal 
manifestations, the main symptoms of which affect the 
musculoskeletal system. It is hypothesized that lymphocytes 
activated in the gut migrate to the joints and trigger the 
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onset of extraintestinal manifestations in the joints 4. Other 
groups of inflammatory pathologies, such as inflammatory 
anemia, peritonitis, ulcer, villous atrophy and appendicitis 
are seen in Crohn's disease. These latter can occur before the 
actual bowel disease is diagnosed. 
Certain risk factors such as tobacco, infection, 
pharmacological agents, stress, pollution and diet have been 
the most incriminated causes of these pathologies 5. 
However, some studies in the development of CD are 
contradictory, as some have found that appendectomy has a 
role in the onset and clinical course of the disease, while 
others have shown that there is no association between 
appendectomy and the development of CD 6. 
In this study, we sought to define the possible associations 
between inflammatory pathology and localization and on the 
other hand, inflammatory pathologies and the disease 
behavior. We also investigated whether one of the 
inflammatory pathologies was more likely to be associated 
with Crohn's disease. 
PATIENTS AND METHODS: 
It was an analytical retrospective study including 295 
patients diagnosed with Crohn's disease at the level of 
gastrology and general surgery services of Western Algerian 
University Hospital "Dr. Hassani Abdelkader" of Sidi Bel 
region, during the period 2007-2019.   
The data collection was carried out using medical records 
including the following medical features: age, sex, location, 
disease behavior, treatment, inflammatory pathologies and 
risk factors. 
Statistical analysis: 
The statistical analytical study and raw data were processed 
using rates and cross-tabulations. Associations between 
categorical parameters were tested using the Chi-square test 
(χ2). The results were presented using the p-value, the level 
of its significance was limited by the 5% rate. All data were 
processed and analyzed by SPSS 20.0 (Statistical Package for 
the Social Sciences, IBM Corporation, Chicago, IL August 
2011). 
RESULTS: 
Our study was based on a total sample of 295 cases involving 
114 females (38.6%) and 181 males (61.4%) with a sex ratio 
of (1.58). The age range was between 16-80 years, which 
represents an average of 38.91. Most of the patients were in 
the age group of 20-40 years (138/74) M/F. We found a 
significant association of 0.02 between inflammatory 
pathology (IP) and Crohn's disease with a percentage of 
12.8% of females and 31.9% of males (Tables 1 and 2).  
The location of the disease at the time of diagnosis was 
dominated by the ileo-caecal location 55.3% and present in 
all age group. 64.4% of them were associated with IP and 
with a significant association (SA) of 0.004. The colonic 
localization detected in the age groups <20-80 years 
(37.6%), of which 28% were associated with IPs and with an 
AS of 0.003. Finally, the jejunal localization with a 
percentage of 7.1% was only present in the age groups 20-
80 years, and only 7.6% of them were associated with IPs 
(Tables 1, 2). 
The majority of patients diagnosed with Crohn's disease had 
an inflammatory behavior (46.8%) and this for all age 
groups. 50.8% of them was associated with inflammatory 
pathologies (Tables 1, 2). Similarly, common studied 
population complained of occlusive syndrome (36.9%), sub-
occlusive syndrome (23.4%), fistula (12.9%), and (6.4%) 
abscess and perineal Sd (Tables 1). 
We also point out that the disease can be diagnosed by 
biological examination and para-clinical examination. 
Biological examination showed that 34.2% of men had 
anemia (<130g/l), however, 24.7% of women had anemia 
(<120g/l). The inflammatory assessment based on CRP and 
Vs showed that 37.3% of patients had CRP (>11mg/l) and 
38% had Vs 1h (>7mm); 2h (>11mm). Serology assessment 
showed that 02% had ASCA positive, 1.7% EBV positive, 
7.1% TB positive, 1.7% Cytomegalovirus, 6.8% ECB and 
0.7% had Varicella zoster virus (Table 1). 
The para-clinical examination study showed that 60.7% 
were examined by ultrasound, 59.7% hail transit, 44.7%  
scan, 38% radiography, 36.3% telethorax, 33.2% barium 
enema and 5.8% PSA. Other patients underwent endoscopic 
examination including 79% colonoscopy and 26.1% 
rectosigmoidoscopy (Table 1). 
Crohn's disease treatment is medical and often surgical, 
indeed, 24.1% are treated with 5-asa, of which 34.8% of its 
patients take 5-asa treatment combined with PIs with a 
highly significant association of <0.0001. 13.6% of patients 
were treated with immunosuppressants.  6.4%, patients 
treated with corticosteroids and biotherapy. Only 6.1% of 
patients receiving biotherapy associated with IP (Table 1,3). 
Sometimes, surgical treatment becomes necessary since 
29.2% of patients underwent ileocaecal resection with 
ileocolic anastomosis, 13.9% right hemi-colectomy, 13.6% 
ileal resection with ileo-leal anastomosis, 10.5% sigmoid 
resection, 5.1% jejunal resection and fistula resection and 
finally 1.4% total coloprotectomy (Table 1). 
With regard to the association of Crohn's disease and 
inflammatory pathologies, two groups have been identified 
that do not differ significantly with age groups, namely 
(Tables 1, 3) : 
- 7.1% have peritonitis, 
- 2.4% have gastritis, 
- 1.7% have ulcerativecolitis, 
- 0.7% have villous atrophy and chronic 
bronchopneumopathy, 
- - 0.3% have meningitis. 
And those that have a significant association with the age 
groups:  
- 33.3% have the appendix at a significant rate (p=0.01) in 
the under-20 age group, however it was 66.7% in the 20-
40 age group. 
- The ulcer appeared with a rate of 33.3% (p=0.02) in the 
under-20age group. It increased to 66.7% in the 20-40 
age group. 
- 66.7% for inflammatory anemia was reported in patients 
with disease started less than 20 years with a highly 
significant rate (p= <0.001). 
For inflammatory extra-intestinal manifestations, we noted 
that only the group of patients with arthralgia (12.5%) had 
significantly higher rates in the 20-40 (p=0.01) and 40-60 
(p=0.02) age groups; however, Ankylosing spondylitis had a 
rate of 7.5% and arthritis a rate of 2.4% (Tables 1, 3). 
We reported as well that all patients who suffered only from 
Crohn's disease had significant rates in the 20-40 year age 
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group (p = 0.004), 40-60 year age group (p = 0.004) and 60-
80 years (p = 0.05). 
The major noted risk factors were: appendectomy with 
(17.3%), smoking 22.4% with a highly significant association 
p= <0.0001 of which 26.5% are associated with IP, and the 
last risk factor was alcoholism 6.1% with p=0.001, of which 
6.8% are associated with IP (Tables 1, 2). 
 
Table 01 : Patients medical features 
Characteristics : Number of cases Percentage % 
Gender   
Female 
male 
114 
181 
38.6 
61.4 
Age range   
>20 years 
20-40 years 
40-60 years 
60-80 years 
14 
212 
55 
14 
4.7 
71.9 
18.6 
4.7 
minimum age  
maximum age 
16 years old 
80 years old 
mean age 38.91 
Standard deviations 14.7 
Age range at presentation   
>20 years 
20-40 years 
40-60 years 
60-80 years 
23 
223 
42 
7 
7.8 
75.6 
14.2 
2.4 
minimum age at presentation 12 years  
Location   
Ileo-caecal location  
Colonic location 
Jejunal location 
163 
111 
21 
55.3 
37.6 
7.1 
Behavior   
Inflammatory.T 
Stenosing.T 
Fistula.T 
ano-perineal.T 
138 
126 
24 
7 
46.8 
42.7 
8.1 
2.4 
Clinical feature   
Pain syndrome  
Occlusive syndrome 
Sub-occlusive syndrome 
Crohn disease 
Fistula 
Abscess 
Perineal syndrome 
19 
109 
69 
27 
38 
19 
14 
6.4 
36.9 
23.4 
9.2 
12.9 
6.4 
4.7 
Biological examination   
CRP (>11mg/l) 
Vs 1h (>7mm) ; 2h (>11mm) 
110 
112 
37.3 
38.0 
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Anemia 
male<130g/l 
Female<120g/l 
 
101 
73 
 
34.2 
24.7 
Serology   
ASCA 
ANCA 
Negative 
Not done  
EBV 
TB 
ECB 
Cytomegalovirus 
Varicelle zona virus 
6 
 
2 
293 
5 
21 
20 
5 
2 
2.0 
 
0.7 
99.3 
1.7 
7.1 
6.8 
1.7 
0.7 
Para-clinical examination   
PSA 
Telethorax 
Radiography 
Barium enema 
hail transit 
Uultrasound 
Scan 
17 
107 
112 
98 
176 
179 
132 
5.8 
36.3 
38.0 
33.2 
59.7 
60.7 
44.7 
Colonoscopy 
Rectosigmoidoscopy 
Fibroscopy 
233 
77 
29 
79 
26.1 
9.8 
Treatment   
5-asa 
Immunosuppressants  
Corticosteroids  
Biotherapy 
71 
40 
19 
19 
24.1 
13.6 
6.4 
6.4 
Operating indications    
Total coloprotectomy 
Right hemi-colectomy 
Fistula resection 
Ileal resection with ileo-leal anastomosis 
Ileocaecal resection with ileocolic anastomosis 
Sigmoid resection 
Jejunal resection 
Not done 
04 
41 
15 
40 
86 
31 
15 
63 
1.4 
13.9 
5.1 
13.6 
29.2 
10.5 
5.1 
21.4 
Inflammatory pathology 132 44.7 
Appendix 
Villous atrophy  
Ulcer 
Chronicbronchopneumopathy 
03 
02 
03 
02 
1.0 
0.7 
1.0 
0.7 
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Meningitis 
Ulcerative colitis 
Crohn disease 
Inflammatory anemia  
Gastritis 
Peritonitis 
01 
05 
90 
03 
07 
21 
0.3 
1.7 
30.5 
1.0 
2.4 
7.1 
Extraintestinal manifestations 
« inflammatory » 
  
Ankylosing spondylitis   
Arthralgia 
Arthritis 
22 
37 
07 
7.5 
12.5 
2.4 
Risk factors   
Appendectomy 
smoking 
Alcoholism 
51 
66 
18 
17.3 
22.4 
6.1 
 
 
Table 02: Association with inflammatory pathology and medical features. 
 
 
Associated with 
inflammatory pathology 
N (%) 
Not associated with 
inflammatory pathology 
  N (%) 
P-Value 
Gender (F/M) 38/94 (28.8/71.2) 76/87 (46.6/53.4) 0.002 
Location    
Colonic localization 37 (28) 73 (44.8) 0.003 
Ileo-caecal location 85 (64.4) 78 (47.9) 0.004 
Jejunal localization 10 (7.6) 11 (6.7) 0.78 
Behavior    
Inflammatory.T 67 (50.8) 71 (43.6) 0.21 
Stenosing.T 52 (39.4) 73 (44.8) 0.35 
Fistula.T 08 (6.1) 16 (9.8) 0.24 
ano-perineal.T 04 (03) 03 (1.8) 0.50 
Treatment    
5-asa 46 (34.8) 25 (15.3) <0.0001 
Immunosuppressants 18 (13.6) 22 (13.5) 0.97 
Corticosteroids 05 (3.8) 14 (8.6) 0.09 
Biotherapy 08 (6.1) 11 (6.7) 0.81 
Smoking 35 (26.5) 31 (19) 0.12 
Alcoholism 09 (6.8) 09 (5.5) 0.64 
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Table 03 : Cumulative extraintestinal manifestations and complications in Crohn’s disease 
Characteristics : >20 20-40 40-60 60-80 
Extraintestinal 
manifestations 
« inflammatory » « n 
(%)p » 
    
Ankylosing spondylitis   01(4.5%) p=0.9 18(81.8%) p=0.2 02(9.1%) p=0.2 01(4.5%) p=0.9 
Arthralgia 01(2.7%) p=0.53 33(89.2%) p=0.01 02(5.4%) p=0.02 01(2.7%) p=0.53 
Arthritis 00 (00) p=0.5 06 (85.7%) p=0.4 01 (14.3%) p=0.7 00 (00) p=0.5 
Inflammatory 
pathology« n (%) p » 
    
Appendix 01 (33.3%)p=0.02 02 (66.7%) p=0.8 00 (00) p=0.4 00 (00) p=0.6 
Villous atrophy  00 (00) p=0.7 02 (100%) p=0.3 00 (00) p=0.5 00 (00) p=0.7 
Ulcer 01 (33.3%)p=0.02 02 (66.7%) p=0.8 00 (00) p=0.4 00 (00) p=0.6 
Chronic 
bronchopneumopathy 
00 (00) p=0.7 01 (50%) p=0.4 01 (50%) p=0.2 00 (00) p=0.7 
Meningitis 00 (00) p=0.8 01 (100%) p=0.5 00 (00) p=0.6 00 (00) p=0.8 
Ulcerative colitis 00 (00) p=0.6 05 (100%) p=0.1 00 (00) p=0.2 00 (00) p=0.6 
Crohn disease 06 (6.7%) p=0.3 75 (83.3%) p=0.004 08 (8.9%)p=0.004 01 (1.1%)p=0.05 
Inflammatory anemia 02 (66.7%) p=<0.0001 00 (00)p=0.005 01 (33.3%) p=0.5 00 (00) p=0.6 
Gastritis 00 (00) p=0.5 07 (100%) p=0.09 00 (00) p=0.2 00 (00)p=0.5 
Peritonitis 00 (00) p=0.2 18 (85.7%) p=0.1 03 (14.3%) p=0.5 00 (00) p=0.2 
 
DISCUSSIONS: 
A total of 297 cases of Crohn's disease were identified during 
the period of 2007-2019.  The median age for developing 
Crohn's disease was about 39 years. In same way, studies of 7 
showed that the median age at diagnosis of CD patients was 
approximately 30 years. However, in the study of 8 the 
patients were younger, since  the minimum age of onset of 
the disease was 12 years. 
The majority of patients were more likely males which is 
consistent with the results of 9–11 but not with those of 7,12. 
 In our study, different segments of the digestive tract were 
affected, but colonic and ileo-cecal localizations were the 
majority. These results are similar to those reported in 
different studies by (Adler et al, 2017; Can et al, 2015; 
Duarte-Silva et al, 2019; Herzog et al, 2018). 
All age groups showed colonic and ileocecal localization, 
which is consistent with the results of (Herzog et al, 2018). 
Whereas, the jejunal localization in our study was more 
present in the age groups of 20-80 years. However, it was 
noted in the patients under the age of 40 in the Herzog 
study. 
Our results showed that the inflammatory and stenosing 
phenotypes were the most frequent, followed by complicated 
cases of fistulas and ano-perineal lesions as confirmed by the 
results of several authors (Feuerstein and Cheifetz, 2017; 
Kugathasan et al, 2017).  
The inflammatory and stenosing types affected all age groups 
of our population, which is consistent with the results of 
(Herzog et al, 2018). 
Moreover, we noticed that the most common symptoms in 
our patients were occlusive Sd, sub-occlusive Sd, abscess and 
fistula, which agrees with13 findings. 
The most altered biological signs in our patients were: 
 CRP >11mg/L, Vs 1h (>7mm); 2h (>11mm) with non-
significant association as reported by 14,15. 
 Anemia in both men (<130) and women (<120) as 
noticed by 16,17. 
 Only 2% of the patients carried out the serological 
assessment with an ASCA positive for the presence of 
the antibodies directed against the mannans in 
particular the Anti-Saccharomyces Cerevisiae "ASCA". 
Gologan S et al (2012) have found that the highest IgA and 
IgG are linked to a younger age at diagnosis and to more 
aggressive phenotypes in Romanian patients with CD 
(Huang et al,) (Gologan et al, 2012). 
7.1% of our patients had a positive TBC. Similarly, studies by 
(Rais et al., 2018) have noted that the digestive tract can also 
be affected by tuberculosis and considered to be a 
granulomatous disease. Therefore, it would be inappropriate 
and even dangerous to treat a patient who actually has 
Crohn's disease with anti-tuberculosis therapy. 
Cytomegalo viruses were noted in 1.7% of patients, ECB in 
6.8% of patients and Varicella zoster virus in 0.7% of 
patients as noted by (Bengi et al, 2018). Colonoscopy was 
the most frequent test of diagnostic with a rate of 79%, 
which is consistent with the results of 18 
Among the 295 studied cases; a highly significant association 
was found between inflammatory pathology and Crohn's 
disease (44.7%). Of these, 7.1% are peritonitis, 2.4% are 
gastritis, 1.7% are UC, 0.7% are villous atrophy and COPD. 
These results are similar to those of 19,20. We also found 0.3% 
cases of meningitis and 01% of appendicitis in the under 20 
age group with a significant rate. These results have been 
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proven by 6,21. Other IPs were found in our study, namely 
ulcers that appear in the under-20 age group and 
inflammatory anemia that occurs at <20-40 years of age. 
Both with a significant association. This is consistent with 
the results of 7.  
In order to control inflammation and to relieve pain in 
Crohn's disease, the first-line treatment prescribed is 
medication. The choice of drug and route of administration 
depends on the intensity of the symptoms and their location 
in the digestive system. In our study 24.1% of patients were 
treated with 5-ASA. This prescription was also noted in the 
study of (Liu et al., 2016). Only 13.6% of patients were 
treated with immunosuppressants to calm the inflammatory 
reactions. These drugs are generally used to maintain 
remission after attack therapy (Hiller et al., 2019; Liu et al., 
2016). As surgical treatment 29.2% of patients underwent 
ileocaecal resection with ileocolic anastomosis, 13.9% 
underwent a right hemi-colectomy which is in accordance 
with the results of 8,22.  
Joint damage is the most common extra-digestive 
manifestation in Crohn's disease. In our study, Arthralgia 
was the most common inflammatory extra-intestinal 
manifestations with a rate of 12.5%. It reaches significantly 
higher rates in the 20-60 age group. These results are 
identical to those of (Herzog et al, 2018). Other studies (Bae 
et al, 2017; Herzog et al, 2018; Hiller et al, 2019; Hsu et al, 
2017) have shown that Crohn's disease develops signs of 
ankylosing spondylitis (AS) affecting joint including that of 
the spine. 7.5% of our patients have developed AS. However, 
in other studies (Bae et al, 2017; Bandyopadhyay et al, 2015; 
Subramaniam et al, 2015), arthritis was the most reported 
whereas in our study we noted only 2.4% of patients 
developing arthritis 
Crohn's disease remains an unknown and as yet ill-defined 
disease, however, medical progress has made it possible to 
move towards the existence of other risk factors. In our 
study 22.4% of patients were smokers (also noticed by 
Bandyopadhyay et al, 2015); 6.1% of men were alcoholic 
and 17.3% of patients had an appendictomy. Ameta-analysis 
of several studies has shown that, despite the heterogeneity, 
there is still a higher relative risk of developing crohn’s 
disease after appendectomy 6,23. 
CONCLUSION: 
This study has shown that the association of inflammatory 
pathologies and Crohn's disease is more common in males; it 
often affects young ages with an ileocecal location and 
dominated by extra-intestinal manifestations of lesions such 
as arthralgia.  
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